Seroprevalencija i faktori rizika za infekciju virusom hepatitisa C u ...
Seroprevalencija i faktori rizika za infekciju virusom hepatitisa C u ...
Seroprevalencija i faktori rizika za infekciju virusom hepatitisa C u ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
8. SUMMARY<br />
We analyzed the seroprevalence, genotypes and risk factors for HCV infection in<br />
groups with high-risk sexual behavior: persons with multiple sexual partners, men<br />
who have sex with men (MSM), commercial sex workers and their clients (CSW)<br />
and persons with sexually transmitted diseases (STDs). Control group consisted of<br />
pregnant females. A total of 821 patients were enrolled in the study: 716 (87.2%)<br />
males and 105 (12.8%) females. The mean age was 35.8+11.5 years. Median age<br />
was 32 years (range 18-77 years). Seventy-one point five percent of participants<br />
reported one risk sexual behavior, 25.2% reported two, 3.2% reported three and<br />
0.1% of participants reported four risk sexual behaviors. Median number of sexual<br />
partner in the preceding year was 2 (range 0-100). A prior history of STDs had<br />
25.3% participants. Hepatitis B virus (HBV) infection was the most frequently<br />
reported (12.8%) followed by gonorrhea (4.6%), C. trachomatis (2.7%) and HPV<br />
infection (2.7%), genital/anal herpes (1.6%) and syphilis (1.0%). The overall HCV<br />
seroprevalence was 4.6%: 6.3% in persons with multiple sexual partners, 2.9% in<br />
MSM, 4.0% in CSW and their clients and 8.5% in persons with STDs compared to<br />
0.5% in control group. HCV seroprevalence was significantly higher than in<br />
controls in all risk groups except MSM [persons with multiple sexual partners:<br />
OR=13.49; 95% CI (OR)=1.81-100.4; CSW and their clients: OR=8.39; 95% CI<br />
(OR)=1.07-65.5; persons with STDs: OR=18.59; 95% CI (OR)=2.4-141.1; MSM<br />
OR=6.00; 95% CI (OR)=0.72-50.2]. The difference of HCV seroprevalence<br />
between age groups was not statistically significant (p=0.230). The highest<br />
seroprevalence was reported in the 20-29 age group (5.8%) and in the 30-39 age<br />
group (5.7%). Neither marital status (p=0.681) nor level of education (p=0.978)<br />
100